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Abstract
Retinal ganglion cell (RGC) death is the end result of practically all diseases of the optic nerve, including glaucomatous optic
neuropathy. Understanding the factors determining susceptibility of the retina or the optic nerve to glaucomatous damage, and the
means to prevent it, requires good animal models. Here we review the diﬀerent, current models in rodents that have been used to
study RGC damage, discuss their value, and their adequacy as models for human glaucoma.  2002 Elsevier Science Ltd. All rights
reserved.
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1. Introduction
Understanding the factors determining susceptibility
of the retina or the optic nerve to glaucomatous damage,
and the means to prevent it require good animal models.
As elevated intraocular pressure (IOP) is considered a
primary risk factor for the initiation and progression of
glaucomatous optic neuropathy (Leske, 1983), the cur-
rent pharmacological therapy for glaucoma relies almost
exclusively on drugs that lower IOP. Yet in many cases,
in spite of adequate IOP control, damage to the optic
nerve continues, as it does in normal tension glaucoma.
For these reasons it would be desirable that the next
generation of anti-glaucoma agents have neuroprotec-
tive eﬀect to prevent or delay the loss of retinal ganglion
cells (RGCs). To discover such agents requires a prac-
tical animal model preferably in rodents, because unlike
the models for IOP-active drugs (such as the lasered
monkey eye), determining RGC survival is terminal for
the experimental animal. Additionally, an ideal glau-
coma animal model should be easy to maintain in a
laboratory environment, be easy to handle, exhibit a
predictable onset and clinical course, and the pathology
should have a reasonably long time course to mimic that
in the human eye (Gelatt, 1977). Studies carried out over
the past two decades have therefore used a variety of
possible glaucoma models induced by diﬀerent mecha-
nisms in rodents. This paper provides a brief review and
assessment of the current status of these diﬀerent rodent
glaucoma models by discussing their pros and cons.
2. Systematics
Medline was used to search the literature from 1966
to the present. Supplemental sources included Index
Medicus and references contained in identiﬁed articles.
Keywords used included RGC, glaucoma, model, rat and
mouse. The English abstracts of foreign language articles
were used, as well as our personal reference library. A
classiﬁcation system was developed to structure the
diﬀerent current models into acute vs. chronic models
and induced vs. spontaneously occurring damage
(Table 1).
One of the main characteristics of glaucoma is the
progressive death of RGCs. However ganglion cell
death is not exclusive to glaucoma and is found in other
retinopathies and optic neuropathies. It is, therefore,
relevant to ask what similarities there are between
glaucoma and the other optic neuropathies. In addition,
it must be determined whether the particular retinal
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pathophysiology or biochemistry of a certain model
makes itmore appropriately applicable to another human
disease.
3. Crush/axotomy model
Schwartz et al. developed a crush model in which a
calibrated and reproducible partial lesion is inﬂicted on
the optic nerve of the adult rat or mouse (Yoles &
Schwartz, 1998a). Using this model, the extent of the
primary damage can be quantiﬁed and a secondary
degeneration demonstrated and assessed. An earlier
similar model is the total axotomy of the optic nerve
(Barron, Dentinger, Krohel, Easton, & Mankes, 1986;
Kikuchi, Tenneti, & Lipton, 2000; Solomon et al.,
1996). Damage inﬂicted directly on the optic nerve ﬁ-
bers inevitably leads to their degeneration and the
eventual death of their cell bodies by apoptosis (Gar-
cia-Valenzuela, Gorczyca, Darzynkiewicz, & Sharma,
1994). Apoptosis may occur due to lack of neurotro-
phin supply from the superior colliculus (retrograde
death) or may be due to the presence of excessive
glutamate or other excitotoxins released in the retina
(anterograde death) (Nickells, 1999). Additionally, over
a period of time neurons that initially escaped the in-
jury may undergo a partial and self-perpetuating sec-
ondary degeneration, the extent of which is a function
of the severity of the primary insult. The proponents of
the crush model suggested that a similar mechanism
may underlie the spread of damage seen in glaucoma at
any given time after the primary cause of the disease
has been eﬀectively treated. That might explain why
patients with severe pre-existing damage were much
more likely to deteriorate even if their IOP was the
same or lower than that of patients without visual
loss at the time of diagnosis (Duvdevani et al., 1990;
Levkovitch-Verbin et al., 2000; Yoles & Schwartz,
1998a,b). Therefore, the aim of the crush model of the
optic nerve was (i) to demonstrate continuing degen-
eration of the optic nerve after elimination of the pri-
mary cause of damage and (ii) to determine whether
secondary degeneration is initiated (Schwartz & Yoles,
1999).
This model has been used extensively to study the
pathophysiologic degradation of the damaged RGC and
its neighboring cells and to test several substances that
can inhibit or slow down these apoptotic signal cascades.
Using this model it was shown that after injury to the
optic nerve, intraocular glutamate and aspartate levels
were signiﬁcantly higher than in normal or sham-oper-
ated eyes, but returned to normal after two weeks (Choi,
1992; Sucher, Lipton, &Dreyer, 1997; Yoles & Schwartz,
1998c). Also using this model the increase in the apop-
tosis eﬀector enzymes caspase 3 and 9 after axotomy
(Kermer et al., 2000; Kermer et al., 1999) and the pos-
sibility of reducing the ganglion cell loss with caspase
inhibitors was shown (Chaudhary, Ahmed, Quebada, &
Sharma, 1999). The ﬁndings that T-cell autoimmunity in
the central nervous system might exert, under certain
circumstances, a beneﬁcial eﬀect by protecting injured
neurons from the spread of damage was demonstrated
using this model in rats and in mice (Fisher et al., 2001;
Moalem et al., 1999; Moalem et al., 2000) as was the
neuroprotective eﬀect of brimonidine (Burke & Sch-
wartz, 1996; Yoles, Wheeler, & Schwartz, 1999).
The crush model mimics very closely the damage
which occurs in traumatic optic neuropathy (TON).
TON results from an indirect trauma to the optic nerve
due to an impact to the head, causing a partial or
complete loss of optic nerve function and, usually, im-
mediate loss of vision. Morphologically an atrophy of
the optic nerve becomes visible after 3–4 weeks. These
injuries appear to involve both mechanical (primary)
and ischemic-induced (secondary) processes that include
degeneration of nerve axons, loss of myelin, and rarely
optic nerve hemorrhage. Free radicals are produced as a
result of the ischemia and hemorrhage, and the evidence
of oxy-radical damage, including lipid peroxidation, is
compelling (Steinsapir & Goldberg, 1994). Therefore it
seems quite likely to many investigators that the ob-
served loss of ganglion cells in TON occurs in a com-
parable way to glaucoma, and the crush model could be
regarded as a highly acute glaucoma model.
Table 1
Current theories for the mechanism of retinal ganglion cell death in glaucoma and corresponding rodent models
Model Theory Mechanism Mouse Rat
Acute Chronic Acute Chronic
Crush/axotomy Retrograde death Interruption of axoplasmatic ﬂow
of growth factors
þ  þ 
Ischemia/reperfusion Ischemic death Hypoxic stress-mediated apoptosis þ  þ 
Excitotoxin injection Anterograde death Neuro-excitatory death   þ (þ)
Vein occlusion, laser,
S-antigen
Elevated IOP Pressure stress induced apoptosis    þ
Spontaneous elevated
IOP
Elevated IOP Pressure stress induced apoptosis  þ  (þ)
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4. Ischemia/reperfusion model
Ischemic retinal injury produced by complete irre-
versible central retinal artery occlusion (CRAO) results
in an inevitable course of necrosis of the retina (Hayreh
& Weingeist, 1980). However experimental studies of
transient (acute) retinal ischemia followed by reperfu-
sion, demonstrated a remarkable tolerance before irre-
versible damage occurred (Kroll, 1968). An extension of
this model was the development of a simple non-vascular
method to cause ischemia––cannulation of the anterior
chamber (AC) with subsequent elevation of the IOP
above systolic blood pressure for various periods of time
in rats and mice (B€uchi, 1992; B€uchi, Suivaizdis, & Fu,
1991; Harada et al., 2000; Hughes, 1991; Selles-Navarro,
Villegas-Perez, Salvador-Silva, Ruiz-Gomez, & Vidal-
Sanz, 1996; Stittsworth & Perlman, 2001; Szabo, Droy-
Lefaix, Doly, Carre, & Braquet, 1991). The aim of this
model was to mimic the possible chronic hypoxic stress
that RGC might undergo in glaucoma. This leads to the
shutdown of all energy dependent functions in the RGC
with subsequent swelling and distinct disruptions of the
mitochondria and degeneration of the neurotubules on
the axons (Adachi, Takahashi, Nishikawa, Miki, &
Uyama, 1996). Furthermore it could be shown that the
delayed cell death found in this transient ischemic model
was not purely necrotic but was caused in part also as a
result of apoptosis associated with elevated p53 protein
levels within the inner retina (Rosenbaum et al., 1997;
Rosenbaum et al., 1998).
The ischemia/reperfusion model has been used mostly
to study damage in RGC. However, because it is not just
a speciﬁc damage to these cells but a general injury to
the whole retina, other neuroscientists use the model to
study damage to the outer retina (Kim et al., 1998). As
had already been shown in the crush model, expression
of Caspases were also upregulated at the protein and
gene levels using this model, giving further evidence for
apoptotic mechanisms involved (Katai & Yoshimura,
1999; Kurokawa et al., 1999; Lam, Abler, & Tso, 1999).
Elevated glutamate levels were found in the vitreous
(Lagreze, Knorle, Bach, & Feuerstein, 1998; Perlman
et al., 1996) and the neuroprotective eﬀect of antagonists
of glutamate or its analogues were shown (Adachi et al.,
1998; Donello, Padillo, Webster, Wheeler, & Gil, 2001;
Kapin, Doshi, Scatton, DeSantis, & Chandler, 1999;
Lagreze, Otto, & Feuerstein, 1999; Osborne, 1999;
Weber, Bonaventure, & Sahel, 1995). Furthermore, it
was found that the level of inducible nitric oxide syn-
thase (iNOS) mRNA expression was markedly increased
in the rat retina following transient ischemia (Hangai,
Yoshimura, Hiroi, Mandai, & Honda, 1996) and that
inhibition of the enzyme partially abolished the ischemic
damage leading to signiﬁcantly longer survival of RGC
(Geyer, Almog, Lupu-Meiri, Lazar, & Oron, 1995; Ju
et al., 2000; Lam & Tso, 1996). Other studies utilizing
this model aimed to conﬁrm results showing a neuro-
protective eﬀect for brimonidine (Wheeler, Lai, &
Woldemussie, 1999) and betaxolol (Osborne, Cazevi-
eille, Carvalho, Larsen, & DeSantis, 1997).
The ischemia/reperfusion model imitates mostly the
type of retinal damage that occurs in CRAO. CRAO is a
well-documented condition that can occur after trauma
and also embolic, thrombotic, or spasmodic episodes,
and causes a selective ischemia to the inner retina. As a
result of CRAO, there is extensive edema and subse-
quent atrophy of the ganglion cell and nerve ﬁber layers,
and severe thinning of the inner nuclear layer. Damage
to the outer retina is less prevalent. Visual ﬁeld defects
are extensive, but central vision may be preserved, as a
result of cilioretinal sparing of part of the macula. Optic
disk cupping is not a recognized consequence to CRAO,
although nonglaucomatous cupping has been reported
in some patients with CRAO (Trobe, Glaser, & Cass-
ady, 1980). The biochemical and clinical changes char-
acteristic of CRAO have some similarities to glaucoma
but the long-term alterations to the retina cannot be
compared between the two diseases.
5. Excitotoxic damage
Excitatory amino acids (e.g. glutamate, aspartate) are
implicated in the pathogenesis of ischemic brain injury.
In the ischemia/reperfusion model, as in the optic nerve
crush model, elevated glutamate levels have been found
in the vitreous, which led to the development of an ex-
citotoxic model. In order to fully understand excitotoxic
involvement in the pathogenesis of retinal ischemic in-
jury, investigators created a model where rats were in-
jected intravitreally with excitatory amino acids or their
analogues (NMDA, kainate and AMPA) to induce
RGC damage (Vorwerk et al., 1996). At lower dose
levels, a single intravitreal injection of NMDA can
damage the ganglion cell layer and the inner plexiform
layer without aﬀecting the other retinal layers (Akaike,
Adachi, & Kaneda, 1998). Intravitreal glutamate injec-
tion demonstrated that excitotoxicity in the adult rat
retina caused severe degenerative changes, which pro-
gressed in two stages: an initial stage of massive cellular
swelling and a second stage of necrosis and cell loss.
Degeneration involved ganglion and inner nuclear layer
cells. Inner retinal thickness decreased concurrently. By
two months post-injection, degenerative changes in rods
and some loss of photoreceptor nuclei were also ob-
served (Sisk & Kuwabara, 1985).
Intravitreal NMDA injection led to the appearance
of internucleosomal fragmentation of retinal DNA
and of terminal transferase dUTP nick-end labeling
(TUNEL)––positive nuclei in the inner retina. Ultra-
structural features consistent with classic apoptotic
changes were noted in degenerating cells in the RGC
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layer and the inner nuclear layer. Control retinas given
vehicle or NMDA plus the glutamate receptor antago-
nist MK-801 did not show these changes. Simultaneous
administration of NMDA and a caspase inhibitor also
abolished or attenuated the loss of RGC in the retina.
The conclusion was drawn that NMDA-induced ex-
citotoxicity involved apoptosis and caspases in their
pathways (Lam, Abler, Kwong, & Tso, 1999). Mor-
phometric analysis of retinal damage in NMDA-injected
eyes also showed that BDNF, nipradilol, MK-801, or
eliprodil could protect inner retinal cells. Furthermore,
measurements of intravitreal glutamate levels indicated
an increase in this excitatory amino acid in the vitreous
after NMDA injection (Kapin et al., 1999; Kido et al.,
2000; Mizuno, Koide, Yoshimura, & Araie, 2001;
Morizane et al., 1997). Another study revealed the up-
regulated expression of glial ﬁbrillary acidic protein
(GFAP) and ciliary neurotrophic factor (CNTF) in
Muller cells in response to NMDA-induced neuronal
death, suggesting that production of CNTF in Muller
cells may be a part of the endogenous neuroprotective
system in the retina (Honjo et al., 2000).
Elevated levels of extracellular glutamate have been
implicated in the pathophysiology of neuronal loss in
central nervous system and ophthalmic disorders. A
twofold elevation in the level of glutamate has been
found in the vitreous body of patients with glaucoma
undergoing cataract extraction when compared with
that of a control population of patients with cataracts
only. A similar elevation of glutamate level was found in
the vitreous body of glaucomatous eyes of monkeys
when compared with that in control eyes. The increased
level of this transmitter is thought to be consistent
with an ‘‘excitotoxic’’ mechanism for the RGC and
optic nerve damage in glaucoma (Dreyer, Zurakowski,
Schumer, Podos, & Lipton, 1996). It is hypothesized
that the increase in glutamate may result from a failure
of the glutamate transporters. Nevertheless the excito-
toxin injection model is self-fulﬁlling for damaging RGC
by injecting a toxic dose of a substance, and thus may
not fully represent glaucoma. Any neurological disease
can be associated with an altered state of excitatory
amino acid turnover/metabolism and therefore it seems
unlikely that this would be a unique feature of glau-
coma.
6. Induction of elevated IOP (vein occlusion, laser,
S-antigen)
Elevated IOP is considered a primary risk factor for
the initiation and progression of glaucomatous optic
neuropathy (Leske, 1983). Therefore the development of
rodent models with surgically induced chronically ele-
vated IOP to study the disease was a major aim. Due to
the small size of mouse eyes, all induced models with
elevated IOP have thus far been developed in the rat.
Various approaches were devised to induce elevated IOP
in the rat eye with the objective of impeding the outﬂow
of aqueous humor. The most commonly used procedure
is the cautery of two or three episcleral/limbal veins
(Mittag et al., 2000; Shareef, Garcia-Valenzuela, Sali-
erno, Walsh, & Sharma, 1995) or injection of hypertonic
saline into limbal aqueous humor collecting veins
(Moore, Milne, & Morrison, 1993; Morrison et al.,
1997). Other methods involve trabecular laser photo-
coagulation after injection of India ink into the AC
(Ueda et al., 1998) or injection of S-antigen (Mermoud,
Baerveldt, Mickler, Wu, & Rao, 1994).
In both the cautery and the saline injection model an
increased number of apoptotic RGCs was found (Gar-
cia-Valenzuela, Shareef, Walsh, & Sharma, 1995;
Johnson, Deppmeier, Wentzien, Hsu, & Morrison,
2000). Also, the optic nerve head depletion of neuro-
trophins coincided with evidence of axonal degenera-
tion, and loss of GFAP staining. Additionally an
increase in soma diameter and expansion of dendritic
ﬁelds in all types of RGCs in eyes with elevated IOP was
described lately (Ahmed Farid, Chaudhary, & Sharma,
2001).
Each of the aforementioned rat glaucoma models has
advantages and disadvantages with its diﬀerent level and
length of time of IOP elevation. The S-antigen injection
model has the advantage of a mean 75% IOP elevation
lasting up to 20 days after induction. Nevertheless the
massive inﬂammatory reaction with its anatomic se-
quelae of uveitis and the invasive intraocular procedure
is its major weakness. The laser photocoagulation model
has the advantage that the initial pathology is localized
to the trabecular meshwork. However, peripheral ante-
rior synechiae develop and multiple laser sessions are
necessary to achieve 60% elevation of IOP. Hypertonic
saline injection has the plus of impeding aqueous out-
ﬂow close to Schlemm’s canal. Potential disadvantages
of this model are that multiple saline injections may be
required, the level of IOP elevation is inconsistent for
individual rats, and optic nerve damage does not show
gradation or correlate completely with time and degree
of IOP elevation. The vein cautery model has the ad-
vantage that it is technically easier than the two models
discussed above and is said to give a more reliable long-
term IOP elevation in groups of animals. The disad-
vantage of the method is that blood ﬂow out of the eye is
impeded by the occlusion of veins leaving the globe,
which could cause obstruction in the intraocular vas-
culature. Thus, the elevation of IOP may be caused in
part by the vascular congestion and by partial block of
aqueous humor outﬂow. Although the retinal blood
vessels appear normal by funduscopic examination
(Neufeld, Sawada, & Becker, 1999; Sawada & Neufeld,
1999), it is uncertain to what degree retinal pathology
may be aﬀected by vascular congestion and/or decreased
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blood ﬂow separate from the elevation of IOP in this
model. The only study comparing the diﬀerent induced
IOP elevation models showed a pressure rise in 100% of
the lasered eyes, a pressure elevation in 49% of the vein
cautery eyes, and of 42% in the hypertonic saline model.
In 83% of the lasered eyes there was optic nerve damage,
which occurred in 36% of the saline injected eyes and
only 20% of eyes in the cautery model (McKinnon et al.,
1999).
7. Spontaneous elevated IOP
Spontaneous occurrence of primary and secondary
glaucoma has been described in some Wistar and
Sprague-Dawley rats (Addison & How, 1926; Heywood,
1975; Young, Festing, & Barnett, 1974). Nevertheless, to
date no high-incidence-rate line could be bred for use in
biomedical research.
In contrast, the DBA/2NNia, DBA/2J and AKXD-
28/Ty inbred mouse strains have been found to spon-
taneously develop a form of secondary glaucoma
(pigment dispersion) in almost 100% of the individuals
(Anderson et al., 2001; John et al., 1998; Sheldon,
Warbritton, Bucci, & Turturro, 1995). Although the
exact genetic defect responsible for all of these pheno-
types has not been yet identiﬁed, it has been shown that
recessive alleles at two loci, termed isa and ipd (chro-
mosome 6 and 4) contribute to the anterior segment
changes (Chang et al., 1999). Pathologic studies indicate
that the changes in these animals start at about 4
months of age with iris pigment epithelium loss and
subsequent iris atrophy at 7 months leading to pro-
gressive closure of the angle and IOP elevation at 8-9
months of age (Pang et al., 1999). This leads to a sig-
niﬁcant reduction of the RGC number and inner plexi-
form layer thickness at 14 months of age followed by
optic nerve damage (Bayer et al., 2001; Williams, Strom,
Rice, & Goldowitz, 1996).
It seems that the mouse system, including the ability
to alter speciﬁc genes, provides a powerful experimental
system for drug studies, hypothesis testing, and genetic
molecular dissection of the pathogenesis. The ability to
control both genetic and environmental factors will al-
low the use of mice to identify genes that modify com-
plex glaucoma phenotypes. By providing a bridge
between gene identiﬁcation and testing for gene func-
tion, mouse studies might become an important com-
plement to glaucoma gene studies in humans and other
species (John, Anderson, & Smith, 1999).
8. Summary
To date no spontaneous model for RGC damage in
the rat is currently known and available for research.
The group of acute induced models in the rat includes
the ischemia/reperfusion and the optic nerve crush
models. The chronic group in the rat includes all models
leading to an IOP elevation lasting for longer than 7
days. This has been achieved by cauterization of three
episcleral veins, by injection of hypertonic saline in the
episcleral veins, by injecting India ink into the AC, laser
scarring of the trabecular meshwork, or by inducing a
uveitic reaction through injection of S-antigen into the
AC. An intermediate model, which can be regarded as
chronic or acute, is multiple single injections respectively
of glutamate or gangliotoxic substances (e.g. NMDA)
into the vitreous humor. In contrast to the rat, there are
mouse strains with spontaneous occurring ocular hy-
pertension (secondary glaucoma) and consecutive gan-
glion cell damage/loss. The substrains identiﬁed are
DBA/2NNia, DBA/2J and AKXD-28/Ty. Acute mouse
models are similar to those in the rat, namely, the optic
nerve crush and ischemia/reperfusion models. No
chronic, induced mouse model as deﬁned above is de-
scribed to date but there is also an intermediate mouse
model induced by injection of gangliotoxic substances
into the vitreous humor.
9. Prospects
The main characteristic feature of glaucoma is the
progressive and relatively slow damage/death of RGCs.
As ganglion cell death is also a feature of a number of
other optic neuropathies and retinopathies, the acute
induced models which are useful in some aspects for
glaucoma research can resemble more closely these
other diseases than they do glaucoma. Examples of such
a resemblance are TON in the case of the optic crush
model and central artery occlusion in the case of the
ischemia/reperfusion model. Therefore, the most rele-
vant rodent glaucoma model should include chronic
elevation of IOP. Due to the diﬃculty in reproducing a
standardized chronic elevated IOP model thus far in the
rat, a main focus of interest should be to discover rodent
strains with spontaneously elevated IOP and to obtain
as complete as possible an understanding of their retinal
pathology.
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